There are provided thieno[2,3-c]pyrazole derivatives of formula (I), wherein A is an aryl or heteroaryl ring, on which the substituent-NHZR
5
is at the ortho position to the CONH linker; R
1
and R
2
are the same or different and, independently from each other, represent a hydrogen atom or an organic group; R
4
is a hydrogen or halogen atom or an organic group; Z is direct bond, >C═O, or —C(═O)NH—; R
5
is hydrogen or an organic group; or isomers, tautomers, carriers, metabolites, prodrugs, and pharamaceutically acceptable salts thereof. A process for their preparation and pharamaceutical compositions comprising them are also disclosed; the compounds of the invention may be useful, in theraphy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
提供了式(I)的
噻吩[2,3-c]
吡唑衍
生物,其中A是芳基或杂环芳基环,其上取代基-NHZR5位于CONH连接基的邻位;R1和R2相同或不同且独立地表示
氢原子或有机基团;R4是
氢原子或卤素原子或有机基团;Z是直接键,>C═O或—C(═O)NH—;R5是
氢原子或有机基团;或其异构体,互变异构体,载体,代谢产物,前药和药物学上可接受的盐。还公开了它们的制备方法和包含它们的药物组合物;该发明的化合物在治疗与蛋白激酶活性失调相关的疾病,如癌症方面可能有用。